mucopolysaccharidosis

(redirected from Mucopolysaccharidosis VI)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to Mucopolysaccharidosis VI: Maroteaux-Lamy syndrome

mucopolysaccharidosis

[¦myü·kō‚päl·ē‚sak·ə·rə′dō·səs]
(medicine)
Any of several inborn metabolic disorders involving mucopolysaccharides; the six types are MPS I, Hurler's syndrome; MPS II, Hunter's syndrome; MPS III, Sanfillipo's syndrome; MPS IV, Morquio's syndrome; MPS V, Scheil's syndrome; and MPS VI, Maroteaux-Lamy's syndrome.
References in periodicals archive ?
Hopwood, Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome), J Pediatr 144(2004), 574-580.
Naglazyme is a normal variant form of arylsulfatase B IUPAC name N-acetylgalactosamin 4-sulfatase) that is lacking in mucopolysaccharidosis VI patients.
Contract award notice: alimentary tract and metabolism of medicines - enzymes to treat mucopolysaccharidosis vi (galsulfase).
Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen.
has begun dosing patients in a Phase 2 clinical trial of Aryplase (recombinant human N-acetylgalactosamine 4-sulfatase or arylsulfatase B), an investigational enzyme replacement therapy for the treatment of mucopolysaccharidosis VI (MPS VI).
The report provides an in-depth analysis of Gaucher's disease, Fabry disease, Pompe disease, mucopolysaccharidosis VI and Niemann-Pick type C.

Full browser ?